Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Robot-assisted Arm Training in Multiple Sclerosis [NA]
The clinical trial assessing robot-assisted arm training for individuals with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS) [NA]
This clinical trial update reports completion and posting of results for a pragmatic dietary program trial in people with Multiple Sclerosis…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Rehabilitation in Multiple Sclerosis - Sometimes Too Much?
A completed clinical trial evaluated rehabilitation strategies for multiple sclerosis. The snippet does not disclose the study results.
-
FDA approval · 2018-06-08FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Betaseron (interferon beta-1b) filed by Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate [Phase 2]
A Phase 2 trial evaluating rituximab induction followed by glatiramer acetate in multiple sclerosis has completed and posted results in June…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple Sclerosis [NA]
A completed clinical trial evaluating internet-based MOTOmed exercise to reduce spasticity and improve physical function in people with Mult…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating the effects of ocrelizumab on immune responses in participants with relapsing forms of multiple sclerosis has compl…
-
CLINICAL_TRIALS research · 2018-05-31Clinical Trial Update: Implementing Physical Activity Guidelines for Adults With MS [NA]
This report summarizes a completed clinical trial that investigates how to implement physical activity guidelines for adults with multiple s…
-
CLINICAL_TRIALS withdrawal · 2018-05-24Clinical Trial Update: Drug Risk Aversion Calculator Use to Facilitate MS Patient Self-efficacy [NA]
A Duke University clinical trial evaluating a Drug Risk Aversion Calculator for facilitating multiple sclerosis patient self-efficacy has be…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis [Phase 1]
Phase 1 safety study evaluating autologous adipose-derived mesenchymal stem cells for multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Cannabis for Spasticity in Multiple Sclerosis [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating cannabis for spasticity in multiple sclerosis was terminated, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Amiloride Clinical Trial In Optic Neuritis [Phase 2]
A Phase 2 trial of amiloride for optic neuritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis [Phase 1]
AbbVie conducted a Phase 1 multiple-dose study of ABT-555 in relapsing forms of multiple sclerosis; the trial status is completed.
-
FDA approval · 2018-05-11FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) filed by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation
Turku University Hospital completed a clinical trial investigating sphingosine-1-phosphate receptor targeting and microglial activation in m…
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis [NA]
An update on a clinical trial investigating microcirculatory alterations and endothelial dysfunction in people with multiple sclerosis using…
-
CLINICAL_TRIALS research · 2018-04-19Clinical Trial Update: Clinical Pilates Training for Persons With Multiple Sclerosis [NA]
This document indicates that a clinical trial evaluating clinical Pilates training for persons with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: Gene Expression in MS Patients Before and During Treatment With Interferon-beta
A clinical trial investigating gene expression in multiple sclerosis patients before and during interferon-beta treatment has been terminate…
-
FDA approval · 2018-04-18FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
FDA approved Biogen's supplemental application for TYSABRI (natalizumab).
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Protective Role of Oxcarbazepine in Multiple Sclerosis [Phase 2]
Phase 2 trial investigating the protective role of oxcarbazepine in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 interventional clinical trial evaluating CCSVI treatment in patients with Multiple Scler…
-
CLINICAL_TRIALS research · 2018-04-17Clinical Trial Update: Cognitive and Emotion Regulation Training in MS [NA]
The clinical trial evaluating cognitive and emotion regulation training for individuals with multiple sclerosis has completed, sponsored by …
-
CLINICAL_TRIALS research · 2018-04-13Clinical Trial Update: Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis [NA]
This clinical trial update describes a study evaluating whether task-oriented training improves functional mobility and reduces fatigue in R…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Vaccine Exposure in Patients With MS
A completed clinical trial update examining vaccine exposure in patients with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Strength Training to Improve Gait in People With Multiple Sclerosis [NA]
This clinical trial update notes the completion of a study evaluating whether strength training improves gait in people with multiple sclero…